Prosthetic valvular endocarditis. A 12-year review.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D001021:Aortic Valve; D002177:Candidiasis / Q000401:mortality; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control / Q000601:surgery; D005260:Female; D006349:Heart Valve Diseases / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D006350:Heart Valve Prosthesis; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D009254:Nafcillin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000401:mortality; D013290:Streptococcal Infections / Q000401:mortality; D013307:Streptomycin / Q000627:therapeutic use; D014261:Tricuspid Valve
D009254:Nafcillin; D007612:Kanamycin; D000667:Ampicillin; D002228:Carbenicillin; D010400:Penicillin G; D002512:Cephalothin; D010068:Oxacillin; D013307:Streptomycin